[3] NAD+ Injection is supplied by compounding pharmacies as a sterile aqueous solution ready for immediate use, typically in vials containing 500 mg or 1,000 mg of NAD+ in solution
REDEFINE 3 evaluates cardiovascular outcomes (~7,000 participants, event-driven)
Pharmacokinetic analysis revealed it to be orally active with significantly increased metabolic stability, exhibiting a plasma half-life of 335.5 minutes, allowing for prolonged systemic availability [2]
As soon as that sterile water hits the lyophilized powder, you've initiated a countdown
While BPC-157 injections face restrictions due to regulatory, safety, and efficacy concerns, the pill form can still be sold as a supplement under different, less stringent regulations